impose relatively quick and effective sanctions on Russia, the sponsor of terrorismus

Each year, billions of dollars are invested by US companies in healthcare sector and associated activities in Russia. Several hundreds of companies are involved in the process so while the impact of a single company is not large - or evident - the combined effect of STOPPING ALL CLINICAL RESEARCH ACTIVITIES IN RUSSIA will mean job cuts for several thousands of Russians, and a dramatic reduction in money influx into the country known to be a sponsor of terrorism. It is a matter of one regulatory body in USA - Food and Drug Administration - to issue a recommendation to US pharma companies and so-called CROs (Clinical Research Organisations) to move their activities elsewhere. No loss for either pharmas or CROs, but a significant blow for Russian economy. Coordination with EU isn't necessary.